JENTADUETO Drug Profile, 2024: JENTADUETO (linagliptin; metformin hydrochloride) drug patents, FDA exclusivity, litigation, drug prices

JENTADUETO Drug Profile, 2024

This report focuses on JENTADUETO and covers the following critical aspects of this drug:

• United States patents
• Expired United States patents
• FDA Paragraph IV patent challenges
• District Court patent litigation
• Patent Trial and Appeal Board (PTAB) patent cases
• European supplementary protection certificates (SPCs)
• Clinical trials
• Drug prices
• Finished product suppliers
• Raw active pharmaceutical ingredient (API) sources

FREE UPDATE: Send your receipt to DrugPatentWatch within 30 days for a free updat

Author: Drugpatentwatch

Publisher: Independently Published

Publication Date: Jan 10, 2024

Number of Pages: 110 pages

Binding: Paperback or Softback

ISBN-10: NA

ISBN-13: 9798875699689